TrialHaematologica2014

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.

Javier Briones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.